Skip to content

EDSA

Healthcare · −3.7% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 8 feeds behind: FDA drug approvals, 1 day, and 7 more · Every feed →

On this page

The market view

Price chart

The interactive EDSA chart (by TradingView) loads here.

Our take

2 rules fired on EDSA

In short: none of these rules has solid or some evidence yet, so they show no clear lean on EDSA.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

The 0–100 score for EDSA, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on EDSA, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Is disclosure activity unusual?

No insider or Congress trades of EDSA are on file, so there is no history to compare. Missing records do not mean no one traded.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

FDA & trials

Owners & lobbying

Company filings · Oct 2026

  1. Filed
All 12 records in this snapshot
  1. Filed
  2. Record date
  3. Filed
  4. Filed
  5. Filed
  6. Filed
  7. Filed
  8. Filed
  9. Filed
  10. Filed
  11. Filed
  12. Record date

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on EDSA disclosed in the last 90 days.

See every Congress trade on EDSA →

Company insiders

No insider buys or sells of EDSA filed in the last 90 days.

See every insider trade on EDSA →

Big holders (Schedule 13D / 13G): 3 filings in the last 90 days · newest: Stonepine Capital Management, LLC (13G), Aug 26, 2026 ↗

Filings & events

Company filings (8-K) 62

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Other events · item 8.0111
  • Quarterly or yearly results · item 2.0210
  • Signed a major agreement · item 1.015
  • Directors or officers joined, left or got new pay · item 5.025
  • Shared information with investors · item 7.013
  • Took on new debt · item 2.033

Filing red flags 41

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

FDA and clinical trials 3

Drug approvals, recalls, clinical-trial updates and FDA advisory meetings.

5% owners (13D / 13G) 15

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 7 filings
  • 13G, just holds: 8 filings

Filed most: Nijhawan Pardeep (4) · Velan Capital Investment Management LP (3) · Stonepine Capital Management, LLC (2) · Integrated Core Strategies (US) LLC (1)

Biggest named funds (13F)

The largest EDSA holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on EDSA

No disclosed trades on EDSA yet — the feeds fill in at the next data publish.

See the trades on EDSA in the feed →
People & votes

Which members of Congress traded EDSA, sponsored bills that touch it and voted on them — opens here.